FMT
ACOR

First Mercantile Trust’s Acorda Therapeutics ACOR Stock Holding History

First Mercantile Trust’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20
Closed -$57K – 839
2017
Q3 		$57K Hold
20
– – 0.01% 766
2017
Q2 		$47K Hold
20
– – 0.01% 791
2017
Q1 		$49K Sell
20
-9
-31% -$25.9K 0.01% 790
2016
Q4 		$65K Buy
29
+1
+4% +$2.38K 0.01% 787
2016
Q3 		$71K Sell
28
-3
-10% -$8.95K 0.01% 772
2016
Q2 		$94K Sell
31
-1
-3% -$3.25K 0.01% 749
2016
Q1 		$101K Sell
32
-3
-9% -$12.5K 0.01% 733
2015
Q4 		$178K Sell
35
-5
-13% -$21.9K 0.02% 673
2015
Q3 		$126K Buy
40
+7
+21% +$27.1K 0.01% 776
2015
Q2 		$130K Hold
33
– – 0.01% 789
2015
Q1 		$132K Buy
33
+4
+14% +$18.3K 0.01% 786
2014
Q4 		$143K Sell
29
-2
-6% -$8.58K 0.01% 749
2014
Q3 		$126K Buy
31
+12
+63% +$45K 0.01% 817
2014
Q2 		$75K Buy
19
+1
+6% +$4.08K 0.01% 878
2014
Q1 		$82K Sell
18
-1
-5% -$4.04K 0.01% 941
2013
Q4 		$66K Hold
19
– – 0.01% 908
2013
Q3 		$77K Sell
19
-36
-65% -$155K 0.01% 867
2013
Q2 		$217K Buy
+55
New +$226K 0.02% 723

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Mercantile Trust's ACOR Position: Q4 2017 in Review

First Mercantile Trust sold out of Acorda Therapeutics (ACOR) in Q4 2017, closing a stake of 20 shares — an estimated $57K sold.

First Mercantile Trust first reported a position in ACOR in Q2 2013 and held it in 18 quarters. The position peaked at $217K in Q2 2013. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

  • First Mercantile Trust reported no remaining Acorda Therapeutics position as of Q4 2017 after selling out during the quarter.
  • First Mercantile Trust sold 20 Acorda Therapeutics shares in Q4 2017, an estimated $57K.
  • First Mercantile Trust first reported a position in Acorda Therapeutics in Q2 2013 and held it in 18 quarters.
  • First Mercantile Trust's Acorda Therapeutics position peaked at $217K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on First Mercantile Trust's 13F filing for Q4 2017, filed 5 Feb 2018.